Immediate Impact
1 from Science/Nature 71 standout
Citing Papers
Aptamers as an approach to targeted cancer therapy
2024 Standout
Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
Works of Herry Patel being referenced
Association between immune-related adverse events (irAEs) and atezolizumab efficacy in advanced NSCLC: analyses from the phase III study OAK
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Herry Patel | 157 | 85 | 49 | 122 | 115 | 28 | 447 | |
| Shea M. Lemley | 65 | 86 | 14 | 79 | 158 | 28 | 382 | |
| Vanessa Morris | 139 | 123 | 63 | 126 | 146 | 16 | 458 | |
| Tashia Petker | 143 | 95 | 78 | 90 | 144 | 14 | 422 | |
| Darren R. Christensen | 162 | 84 | 10 | 80 | 171 | 18 | 425 | |
| Anahí Collado | 214 | 50 | 18 | 124 | 132 | 34 | 450 | |
| Sara Weidberg | 148 | 92 | 27 | 121 | 229 | 49 | 511 | |
| Bruno Kluwe‐Schiavon | 200 | 40 | 17 | 68 | 31 | 44 | 450 | |
| Joshua D. Isen | 177 | 33 | 102 | 111 | 32 | 18 | 428 | |
| Kristen M. Raymond | 213 | 32 | 30 | 120 | 44 | 27 | 509 | |
| Amy M. Loree | 163 | 104 | 105 | 67 | 50 | 36 | 474 |
All Works
Login with ORCID to disown or claim papers
Loading papers...